 available on the beneﬁts of screening
regarding the actual outcomes of future stroke. The
rationale behind screening for asymptomatic disease
has been determined by the assumptions that unheralded stroke is often the ﬁrst symptom of signiﬁcant carotid atherosclerosis and that the medical, surgical, or
endovascular treatment of identiﬁed severe carotid artery stenosis can prevent future cerebral infarction. The
efﬁcacy of